Belkyra®永久溶脂療程

醫生主理
Belkyra® 能高效定點針對脂肪雙下巴。科研實證，有效永久消滅雙下巴脂肪，讓你擺脫雙下巴所帶來的煩惱。3-6
作為世界級首創的溶脂配方，Belkyra®內含專利成分去氧膽酸deoxycholic acid (DCA)，透過直接作用於治療位置的脂肪層，破壞脂肪細胞的細胞膜，導致不可逆轉的脂肪細胞分解。6

Belkyra® is the first-in-class treatment, clinically proven to destroy fat cells under chin to improve submental contour.3-6

With the patent formulation of deoxycholic acid (DCA), which is bioequivalent to the naturally occurring molecule, Belkyra® specifically target to destroy undesired fat, resulting in a noticeable reduction in fullness under the chin.6

【全球唯一FDA認可🤩Belkyra®️永久溶脂療程】主攻顯老雙下巴👍🏻👍🏻👍🏻

⭐️安全可靠
⭐️全球唯一美國FDA及歐洲藥局EMA認可
⭐️世界級首創溶脂配方，Belkyra®️內含專利成分去氧膽酸deoxycholic acid (DCA)
⭐️定點永久摧毀脂肪細胞，無需手術，達致溶脂效果不反彈
⭐️直擊雙下巴脂肪並摧毀脂肪細胞，脂肪細胞，有效減少雙下巴脂肪細胞數量，永久溶脂不反彈
⭐️解決最難減的雙下巴，展現完美V面線條
⭐️5年長期安全數據支持，全球超過20項臨床試驗
⭐️由BOTOX及Juvéderm的制造商Allergan Aesthetics藥廠於美國製造

    立即登記



    *Minimal invasive treatment in adipolysis †Approved as Kybella™ in US10
    ^資料來源：根據美國食物及藥物監督管理局 (U.S. Food and Drug Administration) 官方網站, 去氧膽酸(Belkyra®主要成份) 是唯一認可用作改善雙下巴脂肪8 https://www.fda.gov/search?s=deoxycholic+acid (截至2022年8月9日).
    References: 1. Goodman GJ, et al. Dermatol Surg 2016;42(suppl 1):S260-262. 2. DeFatta R, Ducic Y. Oper Tech Otolaryngol 2007;18(3):261-266. 3. Ascher B, et al. J Eur Acad Dermatol Venereol 2014 Dec;28(12):1707-15. 4. Humphrey S, et al. J Am Acad Dermatol 2016;75(4):788-797; 5. Jones DH, et al. Dermatol Surg 2016;42(1):38-49; 6. Rzany B, et al. Br J Dermatol. 2014;170(2):445-453; 7. Schlessinger J, et al. Skinmed. 2013;11:27–31; 8. Dayan SH, et al. Dermatol Surg 2016;42(suppl 1):S263–S270; 9. Belkyra® Prescribing Information. March 2021; 10. U.S. Food and Drug Administration, Department of Health & Human Services. Kyrbella™ deoxycholic acid injection, 10mg/ml approval letter NDA 206333, Apr 2015; 11. European Medicines Agency. List of nationally authorized medicinal products. EMA/753957/2017. November 2017; 12. Bhatia AC, et al. Poster presented at The Maui Derm for Dermatologists Conference. 20-24 March 2017; 13. Teller CF et al. Plast Reconstr Surg Glob Open. 2021 Jul 12;9(7):e3668; 14. Photo courtesy: Dr Vincent Yang.

    Belkyra® (deoxycholic acid) 藥品註冊編號: HK-65660。Belkyra®為醫生處方藥物，請向醫生或醫學美容中心諮詢切合您獨特需要的專屬療程方案。療程效果因人而異。療程後如有任何不良反應，請即向醫生查詢。All adverse events should be reported to drugsafety.pv@abbvie.com.